Consistent with this, cognitive impairments of the two animal models are corrected by drugs that modulate mGluR5 in the opposite manner (CDPPB for Tsc2+/− mice and MPEP for Fmr1−/y mice). The gene discussed is GRM5; the disease is Cognitive impairment.